NYSE American - Nasdaq Real Time Price USD

Apimeds Pharmaceuticals US, Inc (APUS)

1.8100
-0.3900
(-17.73%)
At close: May 12 at 3:59:55 PM EDT
1.8000
-0.01
(-0.55%)
Pre-Market: 8:34:59 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
1,275.0950
1,275.0950
747.4360
639.5290
1,019.4940
Operating Income
-1,275.0950
-1,275.0950
-747.4360
-639.5290
-1,019.4940
Net Non Operating Interest Income Expense
-114.8950
-114.8950
-30.2580
-29.1370
-6.7400
Pretax Income
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Net Income Common Stockholders
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Diluted NI Available to Com Stockholders
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Basic EPS
-0.13
--
-0.07
-0.06
-0.09
Diluted EPS
-0.13
--
-0.07
-0.06
-0.09
Basic Average Shares
12,693.3980
--
11,526.9430
11,526.9430
11,526.9430
Diluted Average Shares
12,693.3980
--
12,693.3980
12,693.3980
12,693.3980
Total Operating Income as Reported
-1,275.0950
-1,275.0950
-747.4360
-639.5290
-1,019.4940
Total Expenses
1,275.0950
1,275.0950
747.4360
639.5290
1,019.4940
Net Income from Continuing & Discontinued Operation
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Normalized Income
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Interest Income
2.8240
2.8240
7.8110
0
--
Interest Expense
117.7190
117.7190
38.0690
29.1370
6.7400
Net Interest Income
-114.8950
-114.8950
-30.2580
-29.1370
-6.7400
EBIT
-1,272.2710
-1,272.2710
-739.6250
-639.5290
-1,019.4940
EBITDA
-1,272.2710
-1,272.2710
-739.6250
-639.5290
-1,019.4940
Net Income from Continuing Operation Net Minority Interest
-1,389.9900
-1,389.9900
-777.6940
-668.6660
-1,026.2340
Normalized EBITDA
-1,272.2710
-1,272.2710
-739.6250
-639.5290
-1,019.4940
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UPC Universe Pharmaceuticals INC
4.4300
-9.22%
 
PRFX PainReform Ltd.
1.9300
+3.76%
 
PTPI Petros Pharmaceuticals, Inc.
0.1195
-0.50%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2320
-0.22%
 
SXTC China SXT Pharmaceuticals, Inc.
2.1000
+8.25%
 
IXHL Incannex Healthcare Inc.
0.0850
-25.11%
 
SBFM Sunshine Biopharma, Inc.
1.3500
+8.00%
 
ASRT Assertio Holdings, Inc.
0.6154
+0.89%
 
GELS Gelteq Limited
1.4400
+5.11%
 
ANIP ANI Pharmaceuticals, Inc.
62.30
-6.03%